Herpes Encephalitis Masquerading as Tumor by Peeraully, Tasneem & Landolfi, Joseph C.
International Scholarly Research Network
ISRN Neurology
Volume 2011, Article ID 474672, 4 pages
doi:10.5402/2011/474672
Case Report
Herpes EncephalitisMasquerading as Tumor
TasneemPeeraullyand JosephC.Landolﬁ
New Jersey Neuroscience Institute, John F. Kennedy Medical Center, 65 James Street, Edison, NJ 08820 -3947, USA
Correspondence should be addressed to Tasneem Peeraully, tpeeraully@solarishs.org
Received 5 February 2011; Accepted 21 February 2011
Academic Editors: A. Conti and R. Yamanaka
Copyright © 2011 T. Peeraully and J. C. Landolﬁ. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
A 54 year old lady presented with lethargy and 15kg weight loss over the past year. CT scan of the head revealed left temporal
lobe hypodensity with a discrete area of hemorrhage within the left mesial temporal lobe. Due to concerns about impending
central herniation, lumbar puncture was not performed. MRI of the brain showed a large lesion of the left temporal lobe,
extending to the left frontal lobe, and very patchy meningeal enhancement. There was a noncontiguous lesion of the right insula.
Ad i ﬀerential diagnosis of herpes simplex encephalitis (HSE) and multifocal inﬁltrative glioma was entertained. MR spectroscopy
demonstrated an increased choline peak at the level of the medial left temporal lobe and MR perfusion demonstrated patchy
areas of hyperperfusion within the left anterior temporal lobe, both suggestive of neoplastic disease. Following open brain biopsy,
pathology revealed herpes simplex virus (HSV) positive nuclei in the cortex and subcortical white matter. As both herpes simplex
encephalitis and low-grade glioma demontrate MRI ﬁndings of hypointensity on T1 images and hyperintensity on T2 images,
the diagnosis of herpes encephalitis can be clouded by confounding factors, especially when cerebrospinal ﬂuid (CSF) cannot be
obtained.
1.Introduction
Herpes simplex encephalitis has an incidence of 1 in 250,000
to 500,000 persons per year and is the most common spo-
radic fatal encephalitis in the Western world [1]. It typically
presents with headache, fever, and confusion developing
over hours to days. Focal neurological ﬁndings including
hemiparesis, cranial nerve deﬁcits, visual ﬁeld loss, and
dysphasia. Focal or generalized seizures may also be seen
[2]. Patients can exhibit behavioral changes with personality
changes and psychosis.
CT head imaging shows hypodense lesions of the tempo-
rallobeandorbitofrontalregionsandmaydemonstratemass
eﬀect. Petechial hemorrhage may not always be observed
on CT [3, 4]. T2-weighted MRI reveals hyperintensity
corresponding to edematous changes in the temporal lobes,
characteristically sparing the basal ganglia. T1-weighted
images show hypointense signal in the aﬀected areas, and
meningeal enhancement may be demonstrated following the
administration of gadolinium [5].
When CSF can be obtained, it shows mononuclear cell
pleocytosis in 97% of cases, typically with a mildly elevated
protein and a normal glucose [2]. Polymerase chain reaction
(PCR) assays performed on specimens from patients with
brain biopsy-proven herpes simplex encephalitis reveal a
diagnostic sensitivity of 98% at the time of clinical presen-
tation as well as a speciﬁcity approaching 100% [6]. Of note,
negative PCR assay for HSV DNA on the ﬁrst or second day
ofillnessmaybecomepositiveontestingofasubsequentCSF
specimen [7].
Gliomas also demonstrate MRI ﬁndings of hypointensity
on T1 images and hyperintensity on T2 images. Discrete
hemorrhage is more typically seen in tumor than HSE.
Gliomas can be focal, diﬀuse, or multifocal. Though usually
absent, minimal enhancement can occasionally be seen in
glioma. The clinical features of viral encephalitis, namely
headache, fever,seizures, andencephalopathy,maybeseenin
patientswith high-grade gliomas [8]. In cases where imaging
is ambiguousand CSFis not available,biopsymay ultimately
be needed to make a diagnosis.2 ISRN Neurology
Figure 1: CT head: left temporal lobe hypodensity with a discrete
area of hemorrhage.
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Figure 2: MRI T2 FLAIR: hyperintensity of lesions on T2.
2.CaseReport
A 54-year-old female was evaluated for altered mental status
in the emergency room. Eight days prior, the patient had
complained of headache and facial tenderness. She had been
feeling drowsy and unwell, but she had not been febrile. On
the day she was taken to the emergency room, her sister
had found her lethargic and verbalizing poorly. The patient
had been having intermittent headaches for the past year
associated with nausea and vomiting. She had also had 15kg
weight loss over 1 year.
Initially, the patient was oriented to person and place
although lethargic, not communicating well, with slurred
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Figure 3: MR spectroscopy: choline peak (as indicated by arrow) at
the level of the medial left temporal lobe.
speech, poor eye contact, and exhibiting decreased psycho-
motor activity. Her pupils were 3mm and reactive bilat-
erally. Neurological examination was nonfocal except for
brisk reﬂexes in the right upper extremity. Blood work
did not reveal any leukocytosis (white cell count was 6.5
thousand/µL) or electrolyte imbalance. Erythrocyte sedi-
mentation rate was 67mm/hour, and CRP was 7.74mg/dL.
Urine toxicology screening was negative. A CT scan of the
head showed left temporal lobe hypodensity, 8.3 centimeters
in greatest diameter, with areas of hemorrhage within mesial
left temporal lobe (see Figure 1). A lumbar puncture was
not performed because of concerns regarding herniation.
The patient was placed on dexamethasone and acyclovir.
Levetiracetam was started as it was not clear that the patient
whether seizure was responsible for her acute presentation.
MRI of the brain was obtained, showing a large lesion
of the left temporal lobe with extension to the frontal lobe
and noncontiguous ill-deﬁned lesions of the right temporal
l o b e( s e eF i g u r e2). A diﬀerential diagnosis included herpes
encephalitis and inﬁltrative glioma. It was proposed that the
right temporal lesion could represent post-ictal change. MR
spectroscopy demonstrated an increased choline peak at the
levelofthemedial left temporallobe,suggestiveofneoplastic
disease (see Figure 3). MR perfusion demonstrated patchy
areas ofhyperperfusion within theleftperisylvian regionand
left anterior temporal lobe, also supporting a diagnosis of
neoplastic disease.
One week after presentation, patient underwent left tem-
poral craniotomy for open-brain biopsy. Pathology revealed
HSV positive nuclei in the cortex and subcortical white
matter (see Figure 4). Intravenous acyclovir was given for
a total of 21 days. The patient became more responsive but
continued to be disoriented and emotionally labile. She was
released to a subacute rehabilitation facility, and a year after
her symptoms, she was living at home, independent in herISRN Neurology 3
Figure 4: Pathology: HSV positive nuclei.
activities of daily living. On cognitive evaluation, the patient
had some short-term memory and word comprehension
diﬃculties. As she had no clinical seizures during her hos-
pitalization and ambulatory EEG showed only left temporal
lobe slowing, she was weaned oﬀ anticonvulsant medication.
3.Discussion
The diagnosis of HSEcan be cloudedby confounding factors
especially when CSF cannot be obtained. Our patient had
headaches and signiﬁcant weight loss in the months prior
to presentation, supportive of a diagnosis of malignancy.
Although CRP and ESR were elevated, these acute-phase
proteins are not speciﬁc to etiology and may be elevated in
response to tumor, stroke, and seizures as well as infection
and inﬂammation. Pronounced elevations in CRP do not
usually occur in malignancy alone. However, it is not
uncommon for patients with malignancy to have concurrent
illness including infection. Therefore, the context of the case
is important when interpreting these results. Moreover, our
patient was afebrile throughout her hospital course, which is
uncommon in HSE.
Temporal lobe involvement is classical for herpes en-
cephalitis, and the abnormal focus can extend to multiple
lobes, a pattern that can also be seen with inﬁltrative tumors.
While the appearance of hemorrhage on imaging is typically
petechial in HSE, in this case, the appearance of frank
hemorrhage on the initial CT was suspicious for malignancy.
Only patchy meningeal enhancement was seen although the
literature suggests that meningeal enhancement may not be
prominent early on in HSE [3].
MR spectroscopy is nonspeciﬁc and was misleading in
this case. Typical MR spectroscopy ﬁndings in brain neo-
plasms includedecreased N-acetylaspartate (NAA),a marker
of neuronal integrity, increased choline (Cho), representing
cell membrane and myelin turnover, and decreased creatine
(Cr), which provides inorganic phosphates for ATP pro-
duction and hence represent energy stores. Nonneoplastic
disease processes in the CNS including infection may result
in reactive proliferation of cellular elements of the immune
system and of glial tissue, producing MR spectroscopy
proﬁles that are indistinguishable from CNS neoplasms due
to the neuron destroying nature of those lesions [9]. In
looking at the diagnostic accuracy of MR spectroscopy, one
study revealed a sensitivity of 0.95 and a speciﬁcity of 1,
with an accuracy of 0.96, as judged by 4 nonblinded readers
askedtodistinguishneoplastic fromnonneoplastic spectrain
54 patients. When blinded, upon evaluation of 35 untreated
patients, the values were 0.88, 0.80, and 0.86, respectively
[10]. MR spectroscopy in HSE generally shows decreased
NAA/Cr ratios at various time intervals, which could be
compatible with neuronal loss. An increased Cho/Cr ratio
may be seen and is thought to reﬂect myelin breakdown [11–
14].
This case demonstrates the diﬃculty of diagnosis in cer-
tain acutely ill neurological patients. Here, the diagnosis
was between malignancy and HSE. The appropriate workup
(including bloodwork, imaging, and MR spectroscopy) and
therapy (with dexamethasone and acyclovir) were under-
taken. When confounding results occur, we feel that tissue
diagnosis is essential to ensure appropriate disease man-
agement. In this case, biopsy was performed because of
concerns that a lumbar puncture would precipitate central
herniation.
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